NCT04055506View on ClinicalTrials.gov

A Study to Investigate the Effects of Cytochrome P450 1A2 Induction by Ritonavir on BMS-986165 Drug Levels and Effects in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

August 14, 2019

Primary Completion Date

September 21, 2019

Study Completion Date

September 21, 2019

Conditions
Healthy Participants
Interventions
DRUG

BMS-986165

Dose 1

DRUG

Ritonavir

100 mg

Trial Locations (1)

84124

PRA Health Sciences - Salt Lake, Salt Lake City

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY